Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Legend Biotech (LEGN) Revenue (2019 - 2025)

Legend Biotech filings provide 7 years of Revenue readings, the most recent being $306.3 million for Q4 2025.

  • On a quarterly basis, Revenue rose 64.24% to $306.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 64.02% increase, with the full-year FY2025 number at $1.0 billion, up 64.02% from a year prior.
  • Revenue hit $306.3 million in Q4 2025 for Legend Biotech, up from $272.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $79.5 billion in Q4 2023 to a low of $12.0 million in Q2 2022.
  • Median Revenue over the past 5 years was $83.7 million (2023), compared with a mean of $4.1 billion.
  • Biggest five-year swings in Revenue: soared 287469.21% in 2023 and later tumbled 99.77% in 2024.
  • Legend Biotech's Revenue stood at $39.0 million in 2021, then fell by 29.14% to $27.6 million in 2022, then soared by 287469.21% to $79.5 billion in 2023, then tumbled by 99.77% to $186.5 million in 2024, then surged by 64.24% to $306.3 million in 2025.
  • The last three reported values for Revenue were $306.3 million (Q4 2025), $272.3 million (Q3 2025), and $255.1 million (Q2 2025) per Business Quant data.